📊 INMD Key Takeaways
Is INMD a Good Investment? Thesis Analysis
Unable to conduct fundamental analysis due to complete absence of financial data. All income statement, balance sheet, cash flow, and profitability metrics are unavailable, preventing any meaningful assessment of the company's financial health, profitability trends, or growth quality.
Why Buy INMD? Key Strengths
- Company operates in medical device sector (electromedical apparatus) which has structural growth drivers
- Listed on Nasdaq suggesting meets exchange listing standards
- Zero insider selling activity in last 90 days suggests management confidence
INMD Investment Risks to Consider
- No financial data available - unable to assess revenue trends, profitability, or cash generation
- Cannot evaluate balance sheet strength, liquidity position, or leverage levels
- Lack of operating metrics prevents assessment of business fundamentals and operational efficiency
Key Metrics to Watch
- Revenue growth and gross margin trends when data becomes available
- Operating cash flow and free cash flow generation
- Balance sheet composition including debt levels and cash position
INMD Financial Metrics
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
INMD Profitability Ratios
INMD vs Healthcare Sector
How InMode Ltd. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is INMD Overvalued or Undervalued?
Based on fundamental analysis, InMode Ltd. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
INMD Balance Sheet & Liquidity
INMD Growth Metrics (YoY)
INMD SEC 10-K & 10-Q Filing Analysis
Access official SEC EDGAR filings for InMode Ltd. (CIK: 0001742692)
📋 Recent SEC Filings
❓ Frequently Asked Questions about INMD
What is the AI rating for INMD?
InMode Ltd. (INMD) has an AI rating of HOLD with 5% confidence, based on fundamental analysis of SEC EDGAR filings.
What are INMD's key strengths?
Claude: Company operates in medical device sector (electromedical apparatus) which has structural growth drivers. Listed on Nasdaq suggesting meets exchange listing standards.
What are the risks of investing in INMD?
Claude: No financial data available - unable to assess revenue trends, profitability, or cash generation. Cannot evaluate balance sheet strength, liquidity position, or leverage levels.
What is INMD's revenue and growth?
InMode Ltd. reported revenue of N/A.
Does INMD pay dividends?
InMode Ltd. does not currently pay dividends.
Where can I find INMD SEC filings?
Official SEC filings for InMode Ltd. (CIK: 0001742692) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is INMD's EPS?
InMode Ltd. has a diluted EPS of $0.00.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is INMD a good stock to buy right now?
Based on our AI fundamental analysis in March 2026, InMode Ltd. has a HOLD rating with 5% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is INMD stock overvalued or undervalued?
Valuation metrics for INMD: ROE of N/A (sector avg: 15%), net margin of N/A (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy INMD stock in 2026?
Our dual AI analysis gives InMode Ltd. a combined HOLD rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is INMD's free cash flow?
InMode Ltd.'s operating cash flow is N/A, with capital expenditures of N/A.
How does INMD compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin N/A (avg: 12%), ROE N/A (avg: 15%), current ratio N/A (avg: 2).